Publication | Closed Access

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

Molecular VirologyHepatitis CDirect-acting Antivirals DaclatasvirViral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyVirologic EscapeAntiviral DrugMedicine